CLARITY

Last updated

CLARITY [1] is a method of making tissue transparent using acrylamide-based hydrogels built from within, and linked to, the tissue, and as defined in the initial paper, represents "transformation of intact biological tissue into a hybrid form in which specific components are replaced with exogenous elements that provide new accessibility or functionality". [1] When accompanied with antibody or gene-based labeling, CLARITY enables highly detailed pictures of the protein and nucleic acid structure of organs, especially the brain. It was developed by Kwanghun Chung and Karl Deisseroth at the Stanford University School of Medicine. [2]

Contents

Several published papers have applied the CLARITY method to a wide range of tissues and disease states such as immuno-oncology for human breast cancer, [3] Alzheimer's disease human brains, [4] mouse spinal cords, [5] multiple sclerosis animal models, [6] and plants. [7] CLARITY has also been combined with other technologies to develop new microscopy methods including confocal expansion microscopy, SPIM light sheet microscopy, and CLARITY-optimized light sheet microscopy (COLM). [8]

Procedure

A 3-dimensional image taken via the CLARITY technique showing a 1 millimeter slice of mouse hippocampus. The different colors represent proteins stained with fluorescent antibodies. Excitatory neurons are labeled in green, Inhibitory neurons in red, and astrocytes in blue. CLARITY Brain Imaging.jpg
A 3-dimensional image taken via the CLARITY technique showing a 1 millimeter slice of mouse hippocampus. The different colors represent proteins stained with fluorescent antibodies. Excitatory neurons are labeled in green, Inhibitory neurons in red, and astrocytes in blue.

The process of applying CLARITY imaging begins with a postmortem tissue sample. Depending on the tissue type pre-processing steps such as demineralization or decolorization may be necessary after sample fixation. Next a series of chemical treatments must be applied to achieve transparency, in which the lipid content of the sample is removed, while almost all of the original proteins and nucleic acids are left in place. [1] The purpose of this is to make the tissue transparent and thus amenable to detailed microscopic investigation of its constituent functional parts (which are predominantly proteins and nucleic acids). To accomplish this, the preexisting protein structure has to be placed in a transparent scaffolding which preserves it, while the lipid components are removed. This 'scaffolding' is made up of hydrogel monomers such as acrylamide. The addition of molecules like formaldehyde, paraformaldehyde, or glutaraldehyde can facilitate attachment of the scaffolding to the proteins and nucleic acids that are to be preserved, and the addition of heat is necessary to establish the actual linkages between the cellular components and the acrylamide. [9]

Once this step is complete, the protein and nucleic acid components of the target tissue's cells are held firmly in place, while the lipid components remain detached. Lipids are then removed over days to weeks for passive diffusion in detergent, or accelerated by electrophoretic methods to only hours to days. [10] [11] Efforts to accelerate by electrophoretic methods remain inconclusive on ability to not cause tissue damage. As they pass through, the detergent's lipophilic properties enable it to pick up and excise any lipids encountered along the way. Lipophilic dyes as DiI are removed, however there are CLARITY-compatible lipophilic dyes that can be fixated to neighbouring proteins. [12] The large majority of non-lipid molecules, such as proteins and DNA, remain unaffected by this procedure, thanks to the acrylamide gel and chemical properties of the molecules involved. [9]

As reported in the initial paper, the tissue expands during this process, but as needed can be restored to its initial dimensions with a final step of incubation in refractive index matching solution. [1] Tissue expansion does occur in the uniquely lipid-rich brain; however, other tissue types have been noted to not experience as much tissue expansion throughout the process.

By this stage in the process, the sample has been fully prepared for imaging. The contrast for imaging can come from endogenous fluorescent molecules, from nucleic acid (DNA or RNA) labels, or from immunostaining, whereby antibodies that bind specifically to a certain target substance are used. In addition, these antibodies are labeled with Fluorescent tags that are the key to final imaging result. Standard confocal, two-photon, or light-sheet imaging methods are all suitable to then detect the fluorescence emitted down to the scale of protein localization, thus resulting in the final highly detailed and three-dimensional images that CLARITY produces. [9]

After a sample has been immunostained for an image, it is possible to remove the antibodies and re-apply new ones, thus enabling a sample to be imaged multiple times and targeting multiple protein types. [13] [14]

Applications

In terms of brain imaging, the ability for CLARITY imaging to reveal specific structures in such unobstructed detail has led to promising avenues of future applications including local circuit wiring (especially as it relates to the Connectome Project), relationships between neural cells, roles of subcellular structures, better understanding of protein complexes, and imaging of nucleic acids and neurotransmitters. [1] An example of a discovery made through CLARITY imaging is a peculiar 'ladder' pattern where neurons connected back to themselves and their neighbors, which has been observed in animals to be connected to autism-like behaviors. [15]

The CLARITY technique has expanded to several applications beyond the brain. [16] Numerous modifications have been published to build upon the initial publications and efforts have been made both academically and within the biotech industry to apply broad-scope applications to CLARITY. CLARITY continues to gain traction as an emergent technology that can provide powerful insights into clinical diagnostics in the future. CLARITY can be used with little or no modifications to clear most other organs such as liver, pancreas, spleen, testis, and ovaries and other species such as zebrafish. While bone requires a simple decalcification step, similarly, plant tissue requires an enzymatic degradation of the cell wall. [10]

NIH director Francis Collins has already expressed his hopes for this emergent technology, saying: [17]

"CLARITY is powerful. It will enable researchers to study neurological diseases and disorders, focusing on diseased or damaged structures without losing a global perspective. That's something we've never before been able to do in three dimensions."

—  Francis Collins

Limitations

Although the CLARITY procedure has attained unprecedented levels of protein retention after lipid extraction, the technique still loses an estimated 8% of proteins per instance of detergent electrophoresis. [13] Repeated imaging of a single sample would only amplify this loss, as antibody removal is commonly accomplished via the same detergent process that creates the original sample. [9] However, those calculations appear to lack a consistent method for overall protein loss throughout the experiment. ClearLight Biotechnologies, a company founded by Karl Deisseroth, found that the detergent process originally published for antibody removal was not the ideal approach and have developed a destaining solution that was not as detrimental to the tissue integrity.

Other potential disadvantages of the technique are the length of time it takes to create and image a sample (the immunohistochemical staining alone takes up to six weeks to perform), and the fact that the acrylamide used is highly toxic and carcinogenic. Time has often been cited as a limiting factor and disadvantage to using the CLARITY technique; however, several academic and biotech companies (Logos Bioscience, ClearLight Biotechnologies) have continued to develop and optimize CLARITY reagents that significantly truncated the immunostaining time frame reducing the process from six weeks to as quickly as a week depending on sample type. All tissue clearings have their own safety issues. While acrylamide is considered to be toxic and carcinogenic, its components are similar to those found in gels used for western blots.

See also

Related Research Articles

<span class="mw-page-title-main">Gel electrophoresis</span> Method for separation and analysis of biomolecules

Gel electrophoresis is a method for separation and analysis of biomacromolecules and their fragments, based on their size and charge. It is used in clinical chemistry to separate proteins by charge or size and in biochemistry and molecular biology to separate a mixed population of DNA and RNA fragments by length, to estimate the size of DNA and RNA fragments or to separate proteins by charge.

<span class="mw-page-title-main">Histology</span> Study of the microscopic anatomy of cells and tissues of plants and animals

Histology, also known as microscopic anatomy or microanatomy, is the branch of biology that studies the microscopic anatomy of biological tissues. Histology is the microscopic counterpart to gross anatomy, which looks at larger structures visible without a microscope. Although one may divide microscopic anatomy into organology, the study of organs, histology, the study of tissues, and cytology, the study of cells, modern usage places all of these topics under the field of histology. In medicine, histopathology is the branch of histology that includes the microscopic identification and study of diseased tissue. In the field of paleontology, the term paleohistology refers to the histology of fossil organisms.

<span class="mw-page-title-main">Protein</span> Biomolecule consisting of chains of amino acid residues

Proteins are large biomolecules and macromolecules that comprise one or more long chains of amino acid residues. Proteins perform a vast array of functions within organisms, including catalysing metabolic reactions, DNA replication, responding to stimuli, providing structure to cells and organisms, and transporting molecules from one location to another. Proteins differ from one another primarily in their sequence of amino acids, which is dictated by the nucleotide sequence of their genes, and which usually results in protein folding into a specific 3D structure that determines its activity.

<span class="mw-page-title-main">Virology</span> Study of viruses

Virology is the scientific study of biological viruses. It is a subfield of microbiology that focuses on their detection, structure, classification and evolution, their methods of infection and exploitation of host cells for reproduction, their interaction with host organism physiology and immunity, the diseases they cause, the techniques to isolate and culture them, and their use in research and therapy.

<span class="mw-page-title-main">Polyacrylamide gel electrophoresis</span> Analytical technique

Polyacrylamide gel electrophoresis (PAGE) is a technique widely used in biochemistry, forensic chemistry, genetics, molecular biology and biotechnology to separate biological macromolecules, usually proteins or nucleic acids, according to their electrophoretic mobility. Electrophoretic mobility is a function of the length, conformation, and charge of the molecule. Polyacrylamide gel electrophoresis is a powerful tool used to analyze RNA samples. When polyacrylamide gel is denatured after electrophoresis, it provides information on the sample composition of the RNA species.

<span class="mw-page-title-main">Western blot</span> Analytical technique used in molecular biology

The western blot, or western blotting, is a widely used analytical technique in molecular biology and immunogenetics to detect specific proteins in a sample of tissue homogenate or extract. Besides detecting the proteins, this technique is also utilized to visualize, distinguish, and quantify the different proteins in a complicated protein combination.

<span class="mw-page-title-main">Immunostaining</span> Biochemical technique

In biochemistry, immunostaining is any use of an antibody-based method to detect a specific protein in a sample. The term "immunostaining" was originally used to refer to the immunohistochemical staining of tissue sections, as first described by Albert Coons in 1941. However, immunostaining now encompasses a broad range of techniques used in histology, cell biology, and molecular biology that use antibody-based staining methods.

<span class="mw-page-title-main">Immunofluorescence</span> Technique used for light microscopy

Immunofluorescence is a technique used for light microscopy with a fluorescence microscope and is used primarily on biological samples. This technique uses the specificity of antibodies to their antigen to target fluorescent dyes to specific biomolecule targets within a cell, and therefore allows visualization of the distribution of the target molecule through the sample. The specific region an antibody recognizes on an antigen is called an epitope. There have been efforts in epitope mapping since many antibodies can bind the same epitope and levels of binding between antibodies that recognize the same epitope can vary. Additionally, the binding of the fluorophore to the antibody itself cannot interfere with the immunological specificity of the antibody or the binding capacity of its antigen. Immunofluorescence is a widely used example of immunostaining and is a specific example of immunohistochemistry. This technique primarily makes use of fluorophores to visualise the location of the antibodies.

<span class="mw-page-title-main">Single-domain antibody</span> Antibody fragment

A single-domain antibody (sdAb), also known as a Nanobody, is an antibody fragment consisting of a single monomeric variable antibody domain. Like a whole antibody, it is able to bind selectively to a specific antigen. With a molecular weight of only 12–15 kDa, single-domain antibodies are much smaller than common antibodies which are composed of two heavy protein chains and two light chains, and even smaller than Fab fragments and single-chain variable fragments.

<span class="mw-page-title-main">Fixation (histology)</span> Preservation of biological tissue

In the fields of histology, pathology, and cell biology, fixation is the preservation of biological tissues from decay due to autolysis or putrefaction. It terminates any ongoing biochemical reactions and may also increase the treated tissues' mechanical strength or stability. Tissue fixation is a critical step in the preparation of histological sections, its broad objective being to preserve cells and tissue components and to do this in such a way as to allow for the preparation of thin, stained sections. This allows the investigation of the tissues' structure, which is determined by the shapes and sizes of such macromolecules as proteins and nucleic acids.

<span class="mw-page-title-main">Raman microscope</span> Laser microscope used for Raman spectroscopy

The Raman microscope is a laser-based microscopic device used to perform Raman spectroscopy. The term MOLE is used to refer to the Raman-based microprobe. The technique used is named after C. V. Raman, who discovered the scattering properties in liquids.

<span class="mw-page-title-main">DNA nanotechnology</span> The design and manufacture of artificial nucleic acid structures for technological uses

DNA nanotechnology is the design and manufacture of artificial nucleic acid structures for technological uses. In this field, nucleic acids are used as non-biological engineering materials for nanotechnology rather than as the carriers of genetic information in living cells. Researchers in the field have created static structures such as two- and three-dimensional crystal lattices, nanotubes, polyhedra, and arbitrary shapes, and functional devices such as molecular machines and DNA computers. The field is beginning to be used as a tool to solve basic science problems in structural biology and biophysics, including applications in X-ray crystallography and nuclear magnetic resonance spectroscopy of proteins to determine structures. Potential applications in molecular scale electronics and nanomedicine are also being investigated.

<span class="mw-page-title-main">Decellularization</span>

Decellularization is the process used in biomedical engineering to isolate the extracellular matrix (ECM) of a tissue from its inhabiting cells, leaving an ECM scaffold of the original tissue, which can be used in artificial organ and tissue regeneration. Organ and tissue transplantation treat a variety of medical problems, ranging from end organ failure to cosmetic surgery. One of the greatest limitations to organ transplantation derives from organ rejection caused by antibodies of the transplant recipient reacting to donor antigens on cell surfaces within the donor organ. Because of unfavorable immune responses, transplant patients suffer a lifetime taking immunosuppressing medication. Stephen F. Badylak pioneered the process of decellularization at the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. This process creates a natural biomaterial to act as a scaffold for cell growth, differentiation and tissue development. By recellularizing an ECM scaffold with a patient’s own cells, the adverse immune response is eliminated. Nowadays, commercially available ECM scaffolds are available for a wide variety of tissue engineering. Using peracetic acid to decellularize ECM scaffolds have been found to be false and only disinfects the tissue.

<span class="mw-page-title-main">Photoactivatable probes</span> Cellular players that can be activated by light

Photoactivatable probes, or caged probes, are cellular players that can be triggered by a flash of light. They are used in biological research to study processes in cells. The basic principle is to bring a photoactivatable agent to cells, tissues or even living animals and specifically control its activity by illumination.

<span class="mw-page-title-main">Fluorescent in situ sequencing</span>

Fluorescent in situ sequencing (FISSEQ) is a method of sequencing a cell's RNA while it remains in tissue or culture using next-generation sequencing.

Expansion microscopy (ExM) is a sample preparation tool for biological samples that allows investigators to identify small structures by expanding them using a polymer system. The premise is to introduce a polymer network into cellular or tissue samples, and then physically expand that polymer network using chemical reactions to increase the size of the biological structures. Among other benefits, ExM allows those small structures to be imaged with a wider range of microscopy techniques. It was first proposed in a 2015 article by Fei Chen, Paul W. Tillberg, and Edward Boyden. Current research allows for the expansion of samples up to 16x larger than their initial size. This technique has been found useful in various laboratory settings, such as analyzing biological molecules. ExM allows researchers to use standard equipment in identifying small structures, but requires following of procedures in order to ensure clear results.

CUBIC is a histology method that allows tissues to be transparent. As a result, it makes investigation of large biological samples with microscopy easier and faster.

<span class="mw-page-title-main">3DISCO</span>

3DISCO is histological method which make biological samples more transparent, by using series of organic solvents for matching refractive index (RI) of tissue and surrounding medium. Structures in transparent tissues can be examined by fluorescence microscopy without need for time-consuming physical sectioning and following reconstruction in silico.

Tissue clearing refers to a group of chemical techniques used to turn tissues transparent. This allows deep insight into these tissues, while preserving spatial resolution. Many tissue clearing methods exist, each with different strengths and weaknesses. Some are generally applicable, while others are designed for specific applications. Tissue clearing is usually combined with one or more labeling techniques and subsequently imaged, most often by optical sectioning microscopy techniques. Tissue clearing has been applied to many areas in biological research.

<span class="mw-page-title-main">Intracellular delivery</span> Scientific research area

Intracellular delivery is the process of introducing external materials into living cells. Materials that are delivered into cells include nucleic acids, proteins, peptides, impermeable small molecules, synthetic nanomaterials, organelles, and micron-scale tracers, devices and objects. Such molecules and materials can be used to investigate cellular behavior, engineer cell operations or correct a pathological function.

References

  1. 1 2 3 4 5 Chung K, Wallace J, Kim SY, Kalyanasundaram S, Andalman AS, Davidson TJ, Mirzabekov JJ, Zalocusky KA, Mattis J, Denisin AK, Pak S, Bernstein H, Ramakrishnan C, Grosenick L, Gradinaru V, Deisseroth K (May 2013). "Structural and molecular interrogation of intact biological systems". Nature. 497 (7449): 332–7. Bibcode:2013Natur.497..332C. doi:10.1038/nature12107. PMC   4092167 . PMID   23575631.
  2. ↑ Underwood E (April 2013). "Neuroscience. Tissue imaging method makes everything clear". Science. 340 (6129): 131–2. doi:10.1126/science.340.6129.131. PMID   23580500.
  3. ↑ Chen Y, Shen Q, White SL, Gokmen-Polar Y, Badve S, Goodman LJ (April 2019). "Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues". Scientific Reports. 9 (1): 5624. Bibcode:2019NatSR...9.5624C. doi:10.1038/s41598-019-41957-w. PMC   6449377 . PMID   30948791.
  4. ↑ Ando K, Laborde Q, Lazar A, Godefroy D, Youssef I, Amar M, Pooler A, Potier MC, Delatour B, Duyckaerts C (September 2014). "Inside Alzheimer brain with CLARITY: senile plaques, neurofibrillary tangles and axons in 3-D". Acta Neuropathologica. 128 (3): 457–9. doi:10.1007/s00401-014-1322-y. PMC   4131133 . PMID   25069432.
  5. ↑ Zhang MD, Tortoriello G, Hsueh B, Tomer R, Ye L, Mitsios N, Borgius L, Grant G, Kiehn O, Watanabe M, Uhlén M, Mulder J, Deisseroth K, Harkany T, Hökfelt TG (March 2014). "Neuronal calcium-binding proteins 1/2 localize to dorsal root ganglia and excitatory spinal neurons and are regulated by nerve injury". Proceedings of the National Academy of Sciences of the United States of America. 111 (12): E1149-58. Bibcode:2014PNAS..111E1149Z. doi: 10.1073/pnas.1402318111 . PMC   3970515 . PMID   24616509.
  6. ↑ Spence RD, Kurth F, Itoh N, Mongerson CR, Wailes SH, Peng MS, MacKenzie-Graham AJ (November 2014). "Bringing CLARITY to gray matter atrophy". NeuroImage. 101: 625–32. doi:10.1016/j.neuroimage.2014.07.017. PMC   4437539 . PMID   25038439.
  7. ↑ Palmer WM, Martin AP, Flynn JR, Reed SL, White RG, Furbank RT, Grof CP (September 2015). "PEA-CLARITY: 3D molecular imaging of whole plant organs". Scientific Reports. 5: 13492. Bibcode:2015NatSR...513492P. doi:10.1038/srep13492. PMC   4556961 . PMID   26328508.
  8. ↑ Tomer R, Ye L, Hsueh B, Deisseroth K (July 2014). "Advanced CLARITY for rapid and high-resolution imaging of intact tissues". Nature Protocols. 9 (7): 1682–97. doi:10.1038/nprot.2014.123. PMC   4096681 . PMID   24945384.
  9. 1 2 3 4 Geaghan-Breiner C (2013). "CLARITY Brain Imaging". Stanford University.
  10. 1 2 Jensen KH, Berg RW (December 2017). "Advances and perspectives in tissue clearing using CLARITY". Journal of Chemical Neuroanatomy. 86: 19–34. doi:10.1016/j.jchemneu.2017.07.005. PMID   28728966. S2CID   27575056.
  11. ↑ Lee E, Choi J, Jo Y, Kim JY, Jang YJ, Lee HM, Kim SY, Lee HJ, Cho K, Jung N, Hur EM, Jeong SJ, Moon C, Choe Y, Rhyu IJ, Kim H, Sun W (January 2016). "ACT-PRESTO: Rapid and consistent tissue clearing and labeling method for 3-dimensional (3D) imaging". Scientific Reports. 6 (1): 18631. Bibcode:2016NatSR...618631L. doi:10.1038/srep18631. PMC   4707495 . PMID   26750588.
  12. ↑ Jensen KH, Berg RW (September 2016). "CLARITY-compatible lipophilic dyes for electrode marking and neuronal tracing". Scientific Reports. 6: 32674. Bibcode:2016NatSR...632674J. doi:10.1038/srep32674. PMC   5011694 . PMID   27597115.
  13. 1 2 Shen, Helen (April 10, 2013). "See-through brains clarify connections". Nature News.
  14. ↑ Murray E, Cho JH, Goodwin D, Ku T, Swaney J, Kim SY, Choi H, Park YG, Park JY, Hubbert A, McCue M, Vassallo S, Bakh N, Frosch MP, Wedeen VJ, Seung HS, Chung K (December 2015). "Simple, Scalable Proteomic Imaging for High-Dimensional Profiling of Intact Systems". Cell. 163 (6): 1500–14. doi:10.1016/j.cell.2015.11.025. PMC   5275966 . PMID   26638076.
  15. ↑ "See-through brains". Nature Video.
  16. ↑ "Tissue Clearing Applications: CLARITY Beyond the Brain".
  17. ↑ Collins F (11 April 2013). "The Brain: Now You See It, Soon You Won't". NIH Directors Blog. NIH.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.